Arch Pharmalabs

Activities: Ingredients

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Media

Codexis and Arch expand collaboration

<p>Biocatalysis specialist Codexis and Indian active pharmaceutical ingredients (APIs) and intermediates manufacturer, Arch Pharmalabs have expanded their three-year partnership in pharmaceuticals manufacturing</p>
Ingredients

Codexis moves into direct sales of intermediates

<p>US biotechnology company Codexis has made the transition from a technology platform to a product company by commencing direct sales of generic intermediates. It has already received multiple orders for ATS-8, the key chemical intermediate in atorvastatin, the active ingredient in the world's largest selling statin.</p>
Recruitment

People: April 2006

Arch Pharmalabs to open new r&d centre in India

Leading Indian supplier of APIs and intermediates Arch Pharmalabs Ltd, of Mumbai, and its US subsidiary Arch Pharmalabs (USA), of Lexington, Massachusetts, are planning to open a new research and development centre in Taloja, which is situated near Mumbai.

US subsidiary opened by Arch Pharmalabs of India

APIs and pharmaceutical intermediates producer Arch Pharmalabs, based in Mumbai, India, has opened a US subsidiary in Lexington, Massachusetts, headed up by Stuart Needleman.

Codexis expands use of its Proprietary Molecular Breeding technology

Privately held biotechnology company, Codexis has expanded its collaborative programmes by signing agreements with Indian generic pharmaceutical company, Arch Pharmalabs and India\'s Matrix Laboratories, a provider of active pharmaceutical ingredients.
Subscribe now